Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate

Andrologia

Volumn 39, Issue 5, 2007, Pages 181-184

  Yassin, A A ^a,b   Saad, F ^b,c  

^a Segeberger Kliniken   (Germany)

^b GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^c BAYER PHARMA AG   (Germany)

Author keywords

Dihydrotestosterone; Drug profile; Safety; Testosterone undecanoate

Indexed keywords

ANDROSTANOLONE; DUTASTERIDE; TESTOSTERONE UNDECANOATE; AZASTEROID; CHOLESTENONE 5ALPHA REDUCTASE; DRUG DERIVATIVE; ENZYME INHIBITOR; TESTOSTERONE;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MECHANISM; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; BLOOD; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG COMBINATION; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED;

AGED; AZASTEROIDS; CHOLESTENONE 5 ALPHA-REDUCTASE; DIHYDROTESTOSTERONE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HUMANS; HYPOGONADISM; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 35348829162     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2007.00785.x     Document Type: Article

References (15)

1. Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R (2004) Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol 172 : 1314 1317.
2. Behre HM, von Eckardstein S, Kliesch S, Nieschlag E (1999) Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-70 years. Clin Endocrinol (Oxf) 50 : 629 635.
3. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA (1999) Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 84 : 3469 3478.
4. von Eckardstein S, Nieschlag E (2002) Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. J Androl 23 : 419 425.
5. Gooren LJ, Bunck MC (2004) Androgen replacement therapy: present and future. Drugs 64 : 1861 1891.
6. Hijazi RA, Cunningham GR (2005) Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med 56 : 117 137.
7. Kunelius P, Lukkarinen O, Hannuksela ML, Itkonen O, Tapanainen JS (2002) The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab 87 : 1467 1472.
8. de Lignieres B (1993) Transdermal dihydrotestosterone treatment of 'andropause'. Ann Med 25 : 235 241.
9. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ (2001) A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86 : 4078 4088.
10. Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS (2006) Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 296 : 2351 2361.
11. Pratis K, O'Donnell L, Ooi GT, McLachlan RI, Robertson DM (2000) Enzyme assay for 5alpha-reductase type 2 activity in the presence of 5alpha-reductase type 1 activity in rat testis. J Steroid Biochem Mol Biol 75 : 75 82.
12. Russell DW, Wilson JD (1994) Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem 63 : 25 61.
13. Wang C, Swerdloff RS (2002) Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? J Clin Endocrinol Metab 87 : 1462 1466.
14. Wilson JD (1996) Role of dihydrotestosterone in androgen action. Prostate Suppl 6 : 88 92.
15. Wilson JD (2001) The role of 5alpha-reduction in steroid hormone physiology. Reprod Fertil Dev 13 : 673 678.